Prostate Cancer

CRP Predicts Advanced PCa Outcomes

ORLANDO—Blood levels of C-reactive protein (CRP) independently predict survival in men with metastatic androgen-independent prostate cancer (AIPC), researchers conclude. CRP levels also predict the likelihood that patients will respond to therapy.

IMRT Shows Promise for PCa Salvage

ORLANDO—Intensity-modulated radiation therapy (IMRT) may offer a promising salvage option for prostate cancer patients who experience PSA relapse following radical prostatectomy, researchers said.

Higher BMI Increases PCa Death Risk

ORLANDO—Elevated BMI is in-dependently associated with higher prostate cancer-specific mortality (PCSM) following radiation therapy and androgen suppression in men with locally advanced prostate cancer.

Screening Cuts Risk of Advanced PCa

Biennial PSA screening decreases the likelihood of being diagnosed with metastatic prostate cancer, but nearly doubles the chance of being diagnosed with prostate cancer of any type, a Swedish sudy found.

Next post in News